<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Intellectual Property Law Blog &#124; HDP Magazine by Harness Dickey&#187; Featured</title>
	<atom:link href="http://blog.hdp.com/category/featured/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.hdp.com</link>
	<description>Official blog by Harness Dickey, an international and full-service intellectual property legal firm with four locations in the US. Get up-to-date IP info here!</description>
	<lastBuildDate>Fri, 27 Jan 2012 22:44:48 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Patent Attorney, Bob Siminski, Scheduled for Pharma IPR Conference in India</title>
		<link>http://blog.hdp.com/featured/patent-attorney-bob-siminski-scheduled-for-pharma-ipr-conference-in-india/</link>
		<comments>http://blog.hdp.com/featured/patent-attorney-bob-siminski-scheduled-for-pharma-ipr-conference-in-india/#comments</comments>
		<pubDate>Fri, 27 Jan 2012 22:44:48 +0000</pubDate>
		<dc:creator>HDP</dc:creator>
				<category><![CDATA[Featured]]></category>

		<guid isPermaLink="false">http://blog.hdp.com/?p=1442</guid>
		<description><![CDATA[January 31 &#8211; February 2 Harness Dickey attorney Robert Siminski will be attending the Pharma IPR conference in Mumbai, India – January 31.-Feb.2. The conference is intended to bring pharmaceutical patent attorneys together from all over the world to discuss issues relevant to the pharmaceutical industry. &#160; You are invited to follow Mr. Siminski’s blog [...]]]></description>
		<wfw:commentRss>http://blog.hdp.com/featured/patent-attorney-bob-siminski-scheduled-for-pharma-ipr-conference-in-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>USPTO Issues 239346 Trademark Registrations on 2011</title>
		<link>http://blog.hdp.com/featured/uspto-issues-239346-trademark-registrations-on-2011/</link>
		<comments>http://blog.hdp.com/featured/uspto-issues-239346-trademark-registrations-on-2011/#comments</comments>
		<pubDate>Wed, 11 Jan 2012 21:10:23 +0000</pubDate>
		<dc:creator>HDP</dc:creator>
				<category><![CDATA[Featured]]></category>
		<category><![CDATA[Trademarks]]></category>

		<guid isPermaLink="false">http://blog.hdp.com/?p=1414</guid>
		<description><![CDATA[The USPTO issued 239346 trademark registrations in 2011. The most active trademark classes are Class 9 – scientific and electronic apparatus (24,590); Class 16 – printed matter (9692); Class 25 – clothing (14,355). The most active service mark classes are Class 35 – advertising and business (26,542); Class 41 – education and entertainment (23335); and [...]]]></description>
		<wfw:commentRss>http://blog.hdp.com/featured/uspto-issues-239346-trademark-registrations-on-2011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Robert Siminski, Contributing Author of The Innovation Superstar Workbook</title>
		<link>http://blog.hdp.com/featured/robert-siminski-contributing-author-of-the-innovation-superstar-workbook/</link>
		<comments>http://blog.hdp.com/featured/robert-siminski-contributing-author-of-the-innovation-superstar-workbook/#comments</comments>
		<pubDate>Wed, 23 Nov 2011 19:52:35 +0000</pubDate>
		<dc:creator>HDP</dc:creator>
				<category><![CDATA[Featured]]></category>

		<guid isPermaLink="false">http://blog.hdp.com/?p=1406</guid>
		<description><![CDATA[Troy Attorney, Robert Siminski, was recently published as contributing author to The Innovation Superstar Workbook. Robert joined together with author, Nicholas Webb, to write this book focused on innovation. Nicholas Webb describes his book: &#8220;The Innovation Superstar Workbook is based on a large body of knowledge I gained while researching and writing two popular books [...]]]></description>
		<wfw:commentRss>http://blog.hdp.com/featured/robert-siminski-contributing-author-of-the-innovation-superstar-workbook/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bob Siminski Gets Insight from the Korean Patent Court</title>
		<link>http://blog.hdp.com/featured/bob-siminski-gets-insight-from-the-korean-patent-court/</link>
		<comments>http://blog.hdp.com/featured/bob-siminski-gets-insight-from-the-korean-patent-court/#comments</comments>
		<pubDate>Sat, 05 Nov 2011 02:35:39 +0000</pubDate>
		<dc:creator>HDP</dc:creator>
				<category><![CDATA[Featured]]></category>

		<guid isPermaLink="false">http://blog.hdp.com/?p=1400</guid>
		<description><![CDATA[Today I met with the Korean Patent Court (KPC), which is essentially equivalent to the U.S. Court of Appeals for the Federal Circuit (CAFC). Despite its name, the KPC has jurisdiction over a wide variety of intellectual property matters, including copyrights, trademarks, and trade secrets, for example. The Justices at the KPC tend to sit [...]]]></description>
		<wfw:commentRss>http://blog.hdp.com/featured/bob-siminski-gets-insight-from-the-korean-patent-court/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bob Siminski Meets with The Supreme People&#8217;s Court in Asia</title>
		<link>http://blog.hdp.com/featured/bob-siminski-meets-with-the-supreme-peoples-court-in-asia/</link>
		<comments>http://blog.hdp.com/featured/bob-siminski-meets-with-the-supreme-peoples-court-in-asia/#comments</comments>
		<pubDate>Tue, 01 Nov 2011 21:41:21 +0000</pubDate>
		<dc:creator>HDP</dc:creator>
				<category><![CDATA[Featured]]></category>

		<guid isPermaLink="false">http://blog.hdp.com/?p=1397</guid>
		<description><![CDATA[Today I had the privilege of meeting with five Justices of The Supreme People’s Court.  The Justices were very engaging and did a great job educating our group on procedural issues.  We discussed everything from injunctive relief to evidentiary considerations. The Justices were asked why there appears to be great disparity from court to court [...]]]></description>
		<wfw:commentRss>http://blog.hdp.com/featured/bob-siminski-meets-with-the-supreme-peoples-court-in-asia/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bob Siminski&#8217;s First Meeting in Asia</title>
		<link>http://blog.hdp.com/featured/bob-siminskis-first-meeting-in-asia/</link>
		<comments>http://blog.hdp.com/featured/bob-siminskis-first-meeting-in-asia/#comments</comments>
		<pubDate>Mon, 31 Oct 2011 20:18:20 +0000</pubDate>
		<dc:creator>HDP</dc:creator>
				<category><![CDATA[Featured]]></category>

		<guid isPermaLink="false">http://blog.hdp.com/?p=1391</guid>
		<description><![CDATA[This morning I met with a delegation of the State Intellectual Property Office led by Deputy Commissioner Yang Tiejun in Beijing.  He participated in a question and answer session covering various topics.  Some of the more interesting questions and answers were as follows: Q:           Due to government incentives, the number of new patent application filings [...]]]></description>
		<wfw:commentRss>http://blog.hdp.com/featured/bob-siminskis-first-meeting-in-asia/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Patent Attorney, Bob Siminski, Scheduled for Asia Trip with IPO</title>
		<link>http://blog.hdp.com/featured/patent-attorney-bob-siminski-scheduled-for-asia-trip-with-ipo/</link>
		<comments>http://blog.hdp.com/featured/patent-attorney-bob-siminski-scheduled-for-asia-trip-with-ipo/#comments</comments>
		<pubDate>Fri, 21 Oct 2011 21:05:24 +0000</pubDate>
		<dc:creator>HDP</dc:creator>
				<category><![CDATA[Featured]]></category>

		<guid isPermaLink="false">http://blog.hdp.com/?p=1371</guid>
		<description><![CDATA[From Oct. 29 &#8211; Nov.5 Harness Dickey attorney Robert (Bob) Siminski will a delegate of The Intellectual Property Owners Association on an intellectual property rights fact finding trip to China and Korea. In China the delegation will be meeting with the State Intellectual Property Office (SIPO); Supreme People&#8217;s Court; State Administration of Industry and Commerce (SAIC); [...]]]></description>
		<wfw:commentRss>http://blog.hdp.com/featured/patent-attorney-bob-siminski-scheduled-for-asia-trip-with-ipo/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CyberSource v. Retail Decisions, Inc.</title>
		<link>http://blog.hdp.com/featured/cybersource-v-retail-decisions-inc/</link>
		<comments>http://blog.hdp.com/featured/cybersource-v-retail-decisions-inc/#comments</comments>
		<pubDate>Mon, 22 Aug 2011 18:17:28 +0000</pubDate>
		<dc:creator>HDP</dc:creator>
				<category><![CDATA[Featured]]></category>
		<category><![CDATA[Bryan Wheelock]]></category>
		<category><![CDATA[CyberSource]]></category>
		<category><![CDATA[Retail Decisions Inc]]></category>

		<guid isPermaLink="false">http://blog.hdp.com/?p=1364</guid>
		<description><![CDATA[In CyberSource v. Retail Decisions, Inc., No. 2009-1358 (August 16, 2011), the Federal Circuit held that an Internet-related method claim and a “computer readable medium” claim both fail to recite patent-eligible subject matter under 35 U.S.C. § 101, potentially calling into question the validity of many patented claims to devices programmed with software. CyberSource’s U.S. Patent [...]]]></description>
		<wfw:commentRss>http://blog.hdp.com/featured/cybersource-v-retail-decisions-inc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Cost of Sloppy Claim Drafting</title>
		<link>http://blog.hdp.com/featured/the-cost-of-sloppy-claim-drafting/</link>
		<comments>http://blog.hdp.com/featured/the-cost-of-sloppy-claim-drafting/#comments</comments>
		<pubDate>Thu, 18 Aug 2011 18:10:47 +0000</pubDate>
		<dc:creator>HDP</dc:creator>
				<category><![CDATA[Featured]]></category>
		<category><![CDATA[CBT Flint Partners]]></category>
		<category><![CDATA[Return Path Inc]]></category>

		<guid isPermaLink="false">http://blog.hdp.com/?p=1355</guid>
		<description><![CDATA[In CBT Flint Partners, LLC v. Return Path, Inc., No. 2010-1202, -1203 (Fed. Cir. August 10, 2011), CBT appealed a district court’s judgment that a claim was invalid as indefinite.  The claim was for an apparatus comprising a network computer “programmed to detect analyze the electronic mail communication sent by the sending party to determine [...]]]></description>
		<wfw:commentRss>http://blog.hdp.com/featured/the-cost-of-sloppy-claim-drafting/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CAFC MYRIAD DECISION:     This is Not a “Gene Patent” Case</title>
		<link>http://blog.hdp.com/featured/cafc-myriad-decision-this-is-not-a-%e2%80%9cgene-patent%e2%80%9d-case/</link>
		<comments>http://blog.hdp.com/featured/cafc-myriad-decision-this-is-not-a-%e2%80%9cgene-patent%e2%80%9d-case/#comments</comments>
		<pubDate>Thu, 11 Aug 2011 21:13:04 +0000</pubDate>
		<dc:creator>HDP</dc:creator>
				<category><![CDATA[Featured]]></category>
		<category><![CDATA[Amicus]]></category>
		<category><![CDATA[Amicus Brief]]></category>
		<category><![CDATA[AMP v. Myriad Genetics]]></category>
		<category><![CDATA[Biogenerator]]></category>
		<category><![CDATA[Elan Pharmaceuticals]]></category>
		<category><![CDATA[Gilead Sciences]]></category>
		<category><![CDATA[Inc.]]></category>
		<category><![CDATA[Myriad Genetics]]></category>

		<guid isPermaLink="false">http://blog.hdp.com/?p=1329</guid>
		<description><![CDATA[The panel decision in AMP v. Myriad Genetics, written by Judge Lourie, contained law and fact rulings consistent with the  Amicus Brief submitted by HDP on behalf of Gilead Sciences, Inc., Biogenerator and Elan Pharmaceuticals, Inc.   The CAFC held that a synthetic cDNA construct is patent-eligible subject-matter under 35 U.S.C. §101, agreeing with HDP’s assertion that this was [...]]]></description>
		<wfw:commentRss>http://blog.hdp.com/featured/cafc-myriad-decision-this-is-not-a-%e2%80%9cgene-patent%e2%80%9d-case/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

